• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高端流行地区探访者获得的肠道多重耐药菌定植的动力学:一项前瞻性、每日、实时采样研究。

Dynamics of intestinal multidrug-resistant bacteria colonisation contracted by visitors to a high-endemic setting: a prospective, daily, real-time sampling study.

机构信息

Department of Infectious Diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Human Microbiome Research Program, University of Helsinki, Helsinki, Finland.

出版信息

Lancet Microbe. 2021 Apr;2(4):e151-e158. doi: 10.1016/S2666-5247(20)30224-X.

DOI:10.1016/S2666-5247(20)30224-X
PMID:33821248
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8009952/
Abstract

BACKGROUND

Antimicrobial resistance is highly prevalent in low-income and middle-income countries. International travel contributes substantially to the global spread of intestinal multidrug-resistant Gram-negative bacteria. Hundreds of millions of annual visitors to low-income and middle-income countries are all exposed to intestinal multidrug-resistant Gram-negative bacteria resulting in 30-70% of them being colonised at their return. The colonisation process in high-exposure environments is poorly documented because data have only been derived from before travel and after travel sampling. We characterised colonisation dynamics by exploring daily stool samples while visiting a low-income and middle-income countries.

METHODS

In this prospective, daily, real-time sampling study 20 European visitors to Laos volunteered to provide daily stool samples and completed daily questionnaires for 22 days. Samples were initially assessed at Mahosot Hospital, Vientiane, Laos, for acquisition of extended-spectrum β-lactamase-producing (ESBL) Gram-negative bacteria followed by whole-genome sequencing of isolates at MicrobesNG, University of Birmingham, Birmingham, UK. The primary outcome of the study was to obtain data on the dynamics of intestinal multidrug-resistant bacteria acquisition.

FINDINGS

Between Sept 18 and Sept 20, 2015, 23 volunteers were recruited, of whom 20 (87%) European volunteers were included in the final study population. Although colonisation rates were 70% at the end of the study, daily sampling revealed that all participants had acquired ESBL-producing Gram-negative bacteria at some point during the study period; the colonisation status varied day by day. Whole-genome sequencing analysis ascribed the transient pattern of colonisation to sequential acquisition of new strains, resulting in a loss of detectable colonisation by the initial multidrug-resistant Gram-negative strains. 19 (95%) participants acquired two to seven strains. Of the 83 unique strains identified (53 , 10 spp, and 20 other ESBL-producing Gram-negative bacteria), some were shared by as many as four (20%) participants.

INTERPRETATION

To our knowledge, this is the first study to characterise in real-time the dynamics of acquiring multidrug-resistant Gram-negative bacterial colonisation during travel. Our data show multiple transient colonisation events indicative of constant microbial competition and suggest that travellers are exposed to a greater burden of multidrug-resistant bacteria than previously thought. The data emphasise the need for preventing travellers' diarrhoea and limiting antibiotic use, addressing the two major factors predisposing colonisation.

FUNDING

The Finnish Governmental Subsidy for Health Science Research, The Scandinavian Society for Antimicrobial Chemotherapy, the Sigrid Jusélius Foundation, Biotechnology and Biological Sciences Research Council; Wellcome Trust, Medical Research Council; The Royal Society; Joint Programming Initiative on Antimicrobial Resistance, and European Research Council.

摘要

背景

抗微生物药物耐药性在低收入和中等收入国家非常普遍。国际旅行对肠道多重耐药革兰氏阴性菌的全球传播有很大贡献。每年有数亿游客前往低收入和中等收入国家,他们都接触到肠道多重耐药革兰氏阴性菌,其中 30-70%的人在返回时被定植。在高暴露环境中的定植过程记录不佳,因为数据仅来自旅行前和旅行后采样。我们通过探索在低收入和中等收入国家旅行期间的日常粪便样本来描述定植动态。

方法

在这项前瞻性、每日、实时采样研究中,20 名前往老挝的欧洲游客自愿提供每日粪便样本,并在 22 天内完成每日问卷。样本最初在老挝万象的 Mahosot 医院进行评估,以获取产生扩展谱β-内酰胺酶的革兰氏阴性菌(ESBL),然后在英国伯明翰大学的 MicrobesNG 对分离株进行全基因组测序。该研究的主要结果是获得肠道多重耐药菌获得的动态数据。

结果

2015 年 9 月 18 日至 9 月 20 日,招募了 23 名志愿者,其中 20 名(87%)欧洲志愿者被纳入最终研究人群。尽管研究结束时定植率为 70%,但每日采样显示,所有参与者在研究期间的某个时候都已获得 ESBL 产生的革兰氏阴性菌;定植状态每天都在变化。全基因组测序分析将定植的短暂模式归因于新菌株的连续获得,导致最初的多重耐药革兰氏阴性菌株的可检测定植丢失。19 名(95%)参与者获得了 2 到 7 株菌。在 83 个鉴定的独特菌株中(53 个,10 个种和 20 个其他产生 ESBL 的革兰氏阴性菌),有些菌株被多达 4 个(20%)参与者共享。

解释

据我们所知,这是第一项实时描述旅行期间获得多重耐药革兰氏阴性菌定植动态的研究。我们的数据显示了多个短暂的定植事件,表明存在持续的微生物竞争,并表明旅行者接触的多重耐药菌负担比以前认为的要大。这些数据强调了需要预防旅行者腹泻和限制抗生素使用,以解决导致定植的两个主要因素。

资金

芬兰政府卫生科学研究补贴、斯堪的纳维亚抗菌化学学会、西格里德·朱塞利乌斯基金会、生物技术和生物科学研究理事会;惠康信托基金会、医学研究理事会;皇家学会;抗菌药物耐药性联合规划倡议和欧洲研究理事会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf67/8009952/a774aeedb7e1/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf67/8009952/47a96312dcc0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf67/8009952/bdfedabb2d6c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf67/8009952/3096e3264f98/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf67/8009952/80667ae287fb/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf67/8009952/a774aeedb7e1/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf67/8009952/47a96312dcc0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf67/8009952/bdfedabb2d6c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf67/8009952/3096e3264f98/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf67/8009952/80667ae287fb/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf67/8009952/a774aeedb7e1/gr5.jpg

相似文献

1
Dynamics of intestinal multidrug-resistant bacteria colonisation contracted by visitors to a high-endemic setting: a prospective, daily, real-time sampling study.高端流行地区探访者获得的肠道多重耐药菌定植的动力学:一项前瞻性、每日、实时采样研究。
Lancet Microbe. 2021 Apr;2(4):e151-e158. doi: 10.1016/S2666-5247(20)30224-X.
2
Doxycycline as an antimalarial: Impact on travellers' diarrhoea and doxycycline resistance among various stool bacteria - Prospective study and literature review.多西环素作为抗疟药:对旅行者腹泻和各种粪便细菌中多西环素耐药性的影响 - 前瞻性研究和文献综述。
Travel Med Infect Dis. 2022 Sep-Oct;49:102403. doi: 10.1016/j.tmaid.2022.102403. Epub 2022 Jul 21.
3
Multidrug resistance and extended-spectrum beta-lactamase producing Gram-negative bacteria from three Referral Hospitals of Amhara region, Ethiopia.来自埃塞俄比亚阿姆哈拉地区三家转诊医院的耐多药和产超广谱β-内酰胺酶的革兰氏阴性菌。
Ann Clin Microbiol Antimicrob. 2021 Mar 11;20(1):16. doi: 10.1186/s12941-021-00422-1.
4
Gut microbiome perturbation, antibiotic resistance, and Escherichia coli strain dynamics associated with international travel: a metagenomic analysis.肠道微生物组扰动、抗生素耐药性和与国际旅行相关的大肠杆菌菌株动态:一项宏基因组分析。
Lancet Microbe. 2023 Oct;4(10):e790-e799. doi: 10.1016/S2666-5247(23)00147-7. Epub 2023 Sep 13.
5
Travel to Asia and traveller's diarrhoea with antibiotic treatment are independent risk factors for acquiring ciprofloxacin-resistant and extended spectrum β-lactamase-producing Enterobacteriaceae-a prospective cohort study.前往亚洲旅行和抗生素治疗旅行者腹泻是获得环丙沙星耐药和产超广谱β-内酰胺酶肠杆菌科的独立危险因素:一项前瞻性队列研究。
Clin Microbiol Infect. 2016 Aug;22(8):731.e1-7. doi: 10.1016/j.cmi.2016.05.003. Epub 2016 May 17.
6
Oral colonisation by antimicrobial-resistant Gram-negative bacteria among long-term care facility residents: prevalence, risk factors, and molecular epidemiology.长期护理机构居民中耐抗菌药物革兰氏阴性菌的口腔定植:流行率、危险因素和分子流行病学。
Antimicrob Resist Infect Control. 2020 Mar 4;9(1):45. doi: 10.1186/s13756-020-0705-1.
7
High rate of extended-spectrum beta-lactamase-producing gram-negative infections and associated mortality in Ethiopia: a systematic review and meta-analysis.埃塞俄比亚产超广谱β-内酰胺酶的革兰氏阴性菌感染率高且死亡率高:系统评价和荟萃分析。
Antimicrob Resist Infect Control. 2020 Aug 8;9(1):128. doi: 10.1186/s13756-020-00782-x.
8
Multidrug-Resistant Gram-Negative Bacteria and Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae from the Poultry Farm Environment.养殖场环境中产超广谱β-内酰胺酶肺炎克雷伯菌及耐药革兰阴性菌。
Microbiol Spectr. 2022 Jun 29;10(3):e0269421. doi: 10.1128/spectrum.02694-21. Epub 2022 Apr 25.
9
Import and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae by international travellers (COMBAT study): a prospective, multicentre cohort study.国际旅行者携带和传播产超广谱β-内酰胺酶肠杆菌科细菌(COMBAT 研究):一项前瞻性、多中心队列研究。
Lancet Infect Dis. 2017 Jan;17(1):78-85. doi: 10.1016/S1473-3099(16)30319-X. Epub 2016 Oct 14.
10
Microbiota-associated risk factors for asymptomatic gut colonisation with multi-drug-resistant organisms in a Dutch nursing home.荷兰养老院中无症状肠道定植多重耐药菌与微生物群相关的危险因素
Genome Med. 2021 Apr 7;13(1):54. doi: 10.1186/s13073-021-00869-z.

引用本文的文献

1
Within-host bacterial evolution and the emergence of pathogenicity.宿主体内细菌进化与致病性的出现。
Nat Microbiol. 2025 Jul 25. doi: 10.1038/s41564-025-02036-1.
2
Massive culture-based approach for the screening of AmpC, ESBL, and carbapenemase producers from rectal swabs.基于大量培养的方法从直肠拭子中筛选产AmpC酶、超广谱β-内酰胺酶和碳青霉烯酶的菌株。
Microbiol Spectr. 2025 Aug 5;13(8):e0015725. doi: 10.1128/spectrum.00157-25. Epub 2025 Jul 7.
3
Travel to low- and middle-income countries and travellers' diarrhoea increase risk of mismatching antimicrobial therapy for urinary tract infection.

本文引用的文献

1
The evolution and transmission of multi-drug resistant Escherichia coli and Klebsiella pneumoniae: the complexity of clones and plasmids.多重耐药型大肠杆菌和肺炎克雷伯菌的进化和传播:克隆和质粒的复杂性。
Curr Opin Microbiol. 2019 Oct;51:51-56. doi: 10.1016/j.mib.2019.06.004. Epub 2019 Jul 17.
2
Molecular characterization of carbapenem-resistant Escherichia coli and Acinetobacter baumannii in the Lao People's Democratic Republic.老挝人民民主共和国耐碳青霉烯类大肠杆菌和鲍曼不动杆菌的分子特征分析
J Antimicrob Chemother. 2019 Sep 1;74(9):2810-2821. doi: 10.1093/jac/dkz234.
3
Despite Predominance of Uropathogenic/Extraintestinal Pathotypes Among Travel-acquired Extended-spectrum β-Lactamase-producing Escherichia coli, the Most Commonly Associated Clinical Manifestation Is Travelers' Diarrhea.
前往低收入和中等收入国家旅行以及旅行者腹泻会增加尿路感染抗菌治疗不匹配的风险。
J Travel Med. 2025 Apr 25;32(4). doi: 10.1093/jtm/taaf025.
4
Tracking Multidrug Resistance in Gram-Negative Bacteria in Alexandria, Egypt (2020-2023): An Integrated Analysis of Patient Data and Diagnostic Tools.埃及亚历山大市革兰氏阴性菌多重耐药性追踪(2020 - 2023年):患者数据与诊断工具的综合分析
Antibiotics (Basel). 2024 Dec 5;13(12):1185. doi: 10.3390/antibiotics13121185.
5
Longitudinal genomic surveillance of a UK intensive care unit shows a lack of patient colonisation by multi-drug-resistant Gram-negative bacterial pathogens.对英国一家重症监护病房进行的纵向基因组监测显示,患者并未被多重耐药革兰氏阴性细菌病原体定植。
Microb Genom. 2024 Nov;10(11). doi: 10.1099/mgen.0.001314.
6
Genomic epidemiology and longitudinal sampling of ward wastewater environments and patients reveals complexity of the transmission dynamics of -carbapenemase-producing Enterobacterales in a hospital setting.病房废水环境和患者的基因组流行病学及纵向采样揭示了医院环境中产碳青霉烯酶肠杆菌科细菌传播动态的复杂性。
JAC Antimicrob Resist. 2024 Sep 3;6(5):dlae140. doi: 10.1093/jacamr/dlae140. eCollection 2024 Oct.
7
Patient characteristics and antimicrobial susceptibility profiles of Escherichia coli and Klebsiella pneumoniae infections in international travellers: a GeoSentinel analysis.国际旅行者中大肠杆菌和肺炎克雷伯菌感染的患者特征及抗菌药物敏感性概况:一项全球监测网络分析
J Travel Med. 2025 Feb 3;32(1). doi: 10.1093/jtm/taae090.
8
Deep sequencing of Escherichia coli exposes colonisation diversity and impact of antibiotics in Punjab, Pakistan.对大肠杆菌进行深度测序揭示了巴基斯坦旁遮普邦的定植多样性和抗生素的影响。
Nat Commun. 2024 Jun 18;15(1):5196. doi: 10.1038/s41467-024-49591-5.
9
Extra-intestinal pathogenic lineages of extended-spectrum β-lactamase (ESBL)-producing are associated with prolonged ESBL gene carriage.产超广谱β-内酰胺酶(ESBL)的肠外致病谱系与ESBL基因携带时间延长有关。
Access Microbiol. 2024 Feb 12;6(2). doi: 10.1099/acmi.0.000541.v4. eCollection 2024.
10
Effects of breastfeeding on children's gut colonization with multidrug-resistant Enterobacterales in peri-urban Lima, Peru.母乳喂养对秘鲁利马周边地区儿童肠道中产多药耐药肠杆菌定植的影响。
Gut Microbes. 2024 Jan-Dec;16(1):2309681. doi: 10.1080/19490976.2024.2309681. Epub 2024 Feb 1.
尽管旅行者产生的产超广谱β-内酰胺酶大肠埃希菌以尿路致病性/肠外致病性表型为主,但最常见的相关临床表现是旅行者腹泻。
Clin Infect Dis. 2020 Jan 2;70(2):210-218. doi: 10.1093/cid/ciz182.
4
NDM Metallo-β-Lactamases and Their Bacterial Producers in Health Care Settings.在医疗环境中 NDM 型金属β-内酰胺酶及其细菌生产者
Clin Microbiol Rev. 2019 Jan 30;32(2). doi: 10.1128/CMR.00115-18. Print 2019 Mar 20.
5
Acquisition and Loss of CTX-M-Producing and Non-Producing Escherichia coli in the Fecal Microbiome of Travelers to South Asia.旅行者肠道微生物群中 CTX-M 型产酶和不产酶大肠埃希菌的获得和丧失。
mBio. 2018 Dec 11;9(6):e02408-18. doi: 10.1128/mBio.02408-18.
6
Sequence Type 410 Is Causing New International High-Risk Clones.410 型序列正在引发新的国际高风险克隆。
mSphere. 2018 Jul 18;3(4):e00337-18. doi: 10.1128/mSphere.00337-18.
7
Complete genomic characterization of two Escherichia coli lineages responsible for a cluster of carbapenem-resistant infections in a Chinese hospital.完全基因组特征分析两株导致中国医院碳青霉烯类耐药感染聚集性发生的大肠杆菌谱系。
J Antimicrob Chemother. 2018 Sep 1;73(9):2340-2346. doi: 10.1093/jac/dky210.
8
Rapid rise of the ESBL and mcr-1 genes in Escherichia coli of chicken origin in China, 2008-2014.2008-2014 年中国鸡源大肠杆菌中 ESBL 和 mcr-1 基因的快速上升。
Emerg Microbes Infect. 2018 Mar 14;7(1):30. doi: 10.1038/s41426-018-0033-1.
9
Clinically Relevant ESBL-Producing ST307 and ST38 in an Urban West African Rat Population.西非城市大鼠群体中具有临床相关性的产超广谱β-内酰胺酶的ST307和ST38
Front Microbiol. 2018 Feb 9;9:150. doi: 10.3389/fmicb.2018.00150. eCollection 2018.
10
Cryptic transmission of ST405 Escherichia coli carrying bla in hospital.医院中携带 bla 的 ST405 型大肠杆菌的隐秘传播。
Sci Rep. 2018 Jan 10;8(1):390. doi: 10.1038/s41598-017-18910-w.